Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for HIVE. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: HIVE is a Strong Sell candidate.
HIVE price ended at $0.074737 on 土曜日, after rising 1.11%
On Feb 07, 2026 00:00, the price of HIVE rose by 1.11%, climbing from $0.066837 to $0.074737 with 24h trading volume reaching $7.2M HIVE.
